Eli Lilly’s Stock Selloff Is Overdone, Analysts Say. Here’s Why.
In This Article:
Analysts were rushing to reiterate their conviction in the stock following Thursday’s blow to Zepbound and Lilly shares.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Analysts were rushing to reiterate their conviction in the stock following Thursday’s blow to Zepbound and Lilly shares.